The Efficacy of Adalimumab in Children with Chronic Non-infectious Posterior Uveitis and Panuveitis: A Retrospective Cohort Study.
Tianyu TaoShizhao YangDaquan HeXuening PengZhenyu WangQi JiangTianfu WangWenru SuPublished in: Ophthalmology and therapy (2024)
Adalimumab was effective in the treatment of chronic noninfectious posterior uveitis and panuveitis in pediatric patients, and disease inactivity was accomplished in the majority of the patients, thereby improving visual outcomes and maintaining disease stability. Adverse events were limited and tolerable.
Keyphrases
- juvenile idiopathic arthritis
- rheumatoid arthritis
- end stage renal disease
- ankylosing spondylitis
- ejection fraction
- young adults
- peritoneal dialysis
- prognostic factors
- type diabetes
- disease activity
- adipose tissue
- patient reported outcomes
- insulin resistance
- systemic lupus erythematosus
- skeletal muscle
- drug induced
- smoking cessation
- glycemic control